摘要
报告高剂量化疗+自体造血干细胞移植(HDC+AHSCT)治疗4例睾丸非精原细胞瘤(NSGCT)的结果。预处理方案由环磷酰胺(3.0~3.5g/M2)、足叶乙甙(700~1000mg/M2)、卡铂(600~750mg/M2)组成。治疗中骨髓抑制均达Ⅳ度,无Ⅳ度髓外毒性出现。3例初治进展期患者治疗后1例完全缓解,2例部分缓解,其中1例在移植后6个月病情进展,另2例已持续缓解15个月;1例复发患者治疗后肿瘤进展。认为HDC+AHSCT治疗NSGCT的适应证仍有待进一步探索。
4 patients with nonseminomatous germ cell tumor (NSGCT) were treated by highdose chemotherapy and autologous hematopoietic stem cell transplantation (HDC+AHSCT). The preparative regimen consisted of carboplatin 600~750mg/m2,etoposide 700~1 000mg/m2 and cyclophosphamide 3.0~3.5g/m2. All patients were successfully transplanted and no patient experienced nonhematologic toxicity above grade Ⅲ. After HDC+AHSCT, one patient acheived CR, two patients achieved PR, one patient had progressed disease.The role of HDC+AHSCT is still uncertain in the treatment of NSGCT and the dosage of the regimen can be enhanced further.
出处
《中华泌尿外科杂志》
CAS
CSCD
北大核心
1998年第1期45-45,共1页
Chinese Journal of Urology
关键词
造血干细胞
药物疗法
睾丸肿瘤
自体移植
Transplantation, autologous Hematopoietic stem cells Drug therapy Germ cell tumor